Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check12 days agoChange DetectedThe website has been updated to version v2.11.0, while a previous notice regarding delays in displaying study record information has been removed.SummaryDifference4%
- Check19 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.3%
- Check55 days agoChange DetectedThe website has been updated to version 2.10.2 on August 12, 2024, following the removal of version 2.10.0 on July 12, 2024.SummaryDifference0.6%
- Check76 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.